Sign in
CUE Stock Price, Chart, Stats & News
Cue Biopharma, Inc.
Save
69.69M
Market cap
–
Current P/E
–
Forward P/E
CUE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 88.04% |
Operating margin | -96.56% |
Pretax margin | -95.03% |
Net margin | -96.85% |
Effective tax rate | -1.92% |
ROA | -63.02% |
ROE | -165.19% |
D/E | 0.16x |
Interest coverage ratio | -74.29x |
CUE valuation
P/E | – |
P/S | 0.69x |
P/B | 0.98x |
P/CF | -1.19x |
P/FCF | -0.86x |
P/OCF | -1.19x |
PEG | -0.03x |
EV multiple | -1.81x |
About
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a spectrum of severe conditions, such as various cancers, chronic infectious diseases, and autoimmune disorders. The company's leading investigational therapeutic is CUE-101, a specialized fusion protein biologic.
Similar securities
Based on sector and market capitalization
Report issue